In vitro and in vivo protection provided by pinocembrin against lipopolysaccharide-induced inflammatory responses

Pinocembrin or 5, 7-dihydroxyflavanone is a flavanone, a type of flavonoid. In the present study, we first assessed the anti-inflammatory effects of pinocembrin in RAW macrophage cells; and based on these effects, we investigated the therapeutic effects of pinocembrin in murine model of endotoxin-induced acute lung injury. We found that in vitro pretreatment with pinocembrin remarkably regulated the production of TNF-α, IL-1β, IL-6 and IL-10 via inhibiting the phosphorylation of IκBα, ERK1/2, JNK and p38MAPK. In the mouse model of LPS-induced acute lung injury, pinocembrin (20 or 50mg/kg, i.p.) attenuated the development of pulmonary edema, histological severities, as well as neutrophil, lymphocyte and macrophage infiltration, which were increased by LPS administration. Additionally, TNF-α, IL-1β and IL-6 concentrations decreased significantly while the concentration of IL-10 was significantly increased after pinocembrin pretreatment. Our results also showed that pinocembrin attenuated LPS-induced lung injury through suppression of IκBα, JNK and p38MAPK activation. These findings suggest that pinocembrin may represent a novel candidate for the modulation of inflammatory responses. In vitro and in vivo protection provided by pinocembrin (prohibition signs indicate the inhibitory effect of pinocembrin). [Display omitted] ► Pinocembrin regulated the expressions of TNF-α, IL-1β, IL-6 and IL-10 in RAW cells. ► Pinocembrin attenuated lipopolysaccharide (LPS)-induced lung inflammation. ► Pinocembrin blocked LPS-induced MAPK and NF-κB activation in lung tissue.